456 related articles for article (PubMed ID: 29027403)
1. Survival of gynecological cancers in Turkey: where are we at?
Gultekin M; Dundar S; Kucukyildiz I; Karaca MZ; Boztas G; Turan SH; Hacikamiloglu E; Keskinkilic B
J Gynecol Oncol; 2017 Nov; 28(6):e85. PubMed ID: 29027403
[TBL] [Abstract][Full Text] [Related]
2. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.
Kosary CL
Semin Surg Oncol; 1994; 10(1):31-46. PubMed ID: 8115784
[TBL] [Abstract][Full Text] [Related]
3. Survival of Danish cancer patients 1943-1987. Female genital organs.
Kjaer SK; Storm HH
APMIS Suppl; 1993; 33():107-21. PubMed ID: 8512734
[TBL] [Abstract][Full Text] [Related]
4. Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964-2003 followed up to the end of 2006.
Klint A; Tryggvadóttir L; Bray F; Gislum M; Hakulinen T; Storm HH; Engholm G
Acta Oncol; 2010 Jun; 49(5):632-43. PubMed ID: 20307243
[TBL] [Abstract][Full Text] [Related]
5. Trends of Gynecological Cancers in Turkey: Toward Europe or Asia?
Gultekin M; Kucukyildiz I; Karaca MZ; Dundar S; Boztas G; Turan SH; Hacikamiloglu E; Keskinkilic B
Int J Gynecol Cancer; 2017 Oct; 27(8S):S1-S9. PubMed ID: 30819761
[TBL] [Abstract][Full Text] [Related]
6. Reliability of recording uterine cancer in death certification in France and age-specific proportions of deaths from cervix and corpus uteri.
Rogel A; Belot A; Suzan F; Bossard N; Boussac M; Arveux P; Buémi A; Colonna M; Danzon A; Ganry O; Guizard AV; Grosclaude P; Velten M; Jougla E; Iwaz J; Estève J; Chérié-Challine L; Remontet L
Cancer Epidemiol; 2011 Jun; 35(3):243-9. PubMed ID: 21106450
[TBL] [Abstract][Full Text] [Related]
7. Trends of Gynecological Cancers in Turkey: Toward Europe or Asia?
Gultekin M; Kucukyildiz I; Karaca MZ; Dundar S; Boztas G; Turan SH; Hacikamiloglu E; Keskinkilic B
Int J Gynecol Cancer; 2017 Oct; 27(8S Suppl 1):S1-S9. PubMed ID: 28937544
[TBL] [Abstract][Full Text] [Related]
8. Trends of Gynecological Cancers in Turkey: Toward Europe or Asia?
Gultekin M; Kucukyildiz I; Karaca MZ; Dundar S; Boztas G; Turan SH; Hacikamiloglu E; Keskinkilic B
Int J Gynecol Cancer; 2017 Sep; 27(7):1525-1533. PubMed ID: 28708790
[TBL] [Abstract][Full Text] [Related]
9. Trends in gynecologic cancer among elderly women in Denmark, 1980-2012.
Ør Knudsen A; Schledermann D; Nyvang GB; Mogensen O; Herrstedt J;
Acta Oncol; 2016; 55 Suppl 1():65-73. PubMed ID: 26784001
[TBL] [Abstract][Full Text] [Related]
10. Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma.
Yokoi E; Mabuchi S; Takahashi R; Matsumoto Y; Kuroda H; Kozasa K; Kimura T
J Gynecol Oncol; 2017 Mar; 28(2):e19. PubMed ID: 28028992
[TBL] [Abstract][Full Text] [Related]
11. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy.
Clavero JM; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Barrette BA; Larson DR; Pairolero PC
Ann Thorac Surg; 2006 Jun; 81(6):2004-7. PubMed ID: 16731120
[TBL] [Abstract][Full Text] [Related]
12. Gynecological cancers: cervix, corpus uteri, ovary.
Zambon P; La Rosa F
Epidemiol Prev; 2004; 28(2 Suppl):68-74. PubMed ID: 15281609
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis.
Gibbs J; Mei S; Economos K; Lee YC; Kanis MJ
Am J Obstet Gynecol; 2019 Jul; 221(1):53.e1-53.e6. PubMed ID: 30849352
[TBL] [Abstract][Full Text] [Related]
14. A population-based survey of the management of women with cancer of the cervix.
Clarke F; Dey P; Collins S
Br J Cancer; 1999 Aug; 80(12):1958-61. PubMed ID: 10471045
[TBL] [Abstract][Full Text] [Related]
15. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
[TBL] [Abstract][Full Text] [Related]
16. Trends in gynecologic cancer in Japan: incidence from 1980 to 2019 and mortality from 1981 to 2021.
Nakai H; Higashi T; Kakuwa T; Matsumura N
Int J Clin Oncol; 2024 Apr; 29(4):363-371. PubMed ID: 38381162
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer incidence and survival in Korea: 1993-2002.
Chung HH; Jang MJ; Jung KW; Won YJ; Shin HR; Kim JW; Lee HP;
Int J Gynecol Cancer; 2006; 16(5):1833-8. PubMed ID: 17009979
[TBL] [Abstract][Full Text] [Related]
18. Survival differences in women with serous tubal, ovarian, peritoneal, and uterine carcinomas.
Usach I; Blansit K; Chen LM; Ueda S; Brooks R; Kapp DS; Chan JK
Am J Obstet Gynecol; 2015 Feb; 212(2):188.e1-6. PubMed ID: 25149685
[TBL] [Abstract][Full Text] [Related]
19. Incidence and survival trends of uncommon corpus uteri malignancies in the Netherlands, 1989-2008.
Boll D; Verhoeven RH; van der Aa MA; Pauwels P; Karim-Kos HE; Coebergh JW; van Doorn HC
Int J Gynecol Cancer; 2012 May; 22(4):599-606. PubMed ID: 22398706
[TBL] [Abstract][Full Text] [Related]
20. Stage at diagnosis and mortality in patients with adenocarcinoma and adenosquamous carcinoma of the uterine cervix diagnosed as a consequence of cytologic screening.
Kinney W; Sawaya GF; Sung HY; Kearney KA; Miller M; Hiatt RA
Acta Cytol; 2003; 47(2):167-71. PubMed ID: 12685183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
